- Home
- AVT vs ACLX Comparison
AVT vs ACLX Comparison
Compare AVT & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVT
- ACLX
- Stock Information
- Founded
- AVT 1921
- ACLX 2015
- Country
- AVT United States
- ACLX United States
- Employees
- AVT N/A
- ACLX N/A
- Industry
- AVT Electronic Components
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- AVT Technology
- ACLX Health Care
- Exchange
- AVT Nasdaq
- ACLX Nasdaq
- Market Cap
- AVT 4.3B
- ACLX 4.4B
- IPO Year
- AVT N/A
- ACLX 2022
- Fundamental
- Price
- AVT $51.74
- ACLX $88.70
- Analyst Decision
- AVT Sell
- ACLX Strong Buy
- Analyst Count
- AVT 3
- ACLX 12
- Target Price
- AVT $49.00
- ACLX $114.75
- AVG Volume (30 Days)
- AVT 714.1K
- ACLX 511.7K
- Earning Date
- AVT 10-29-2025
- ACLX 11-06-2025
- Dividend Yield
- AVT 2.55%
- ACLX N/A
- EPS Growth
- AVT N/A
- ACLX N/A
- EPS
- AVT 2.75
- ACLX N/A
- Revenue
- AVT $22,200,754,000.00
- ACLX $56,979,000.00
- Revenue This Year
- AVT $5.60
- ACLX N/A
- Revenue Next Year
- AVT $5.99
- ACLX $210.71
- P/E Ratio
- AVT $18.82
- ACLX N/A
- Revenue Growth
- AVT N/A
- ACLX N/A
- 52 Week Low
- AVT $39.22
- ACLX $47.86
- 52 Week High
- AVT $59.24
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- AVT 42.97
- ACLX 68.46
- Support Level
- AVT $51.26
- ACLX $83.33
- Resistance Level
- AVT $52.99
- ACLX $89.31
- Average True Range (ATR)
- AVT 0.89
- ACLX 2.66
- MACD
- AVT -0.10
- ACLX 0.42
- Stochastic Oscillator
- AVT 7.18
- ACLX 63.77
About AVT Avnet Inc.
Avnet Inc is an electronic component technology distributor and solutions provider. It serves customers from startups and mid-sized businesses to enterprise-level original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, and original design manufacturers (ODMs). The group operates in the Electronic Components segment and supports high and medium-volume customers to markets, sells, and distributes electronic components, and the Farnell segment supports lower-volume customers that need electronic components quickly to develop, prototype, and test their products. Its geographic regions are the Americas, EMEA, and Asia.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.